Protagonist Therapeutics, Inc news PTGX
Plain-English coverage of this company’s material 8-K filings — generated from the primary source the moment they file.
← back to Protagonist Therapeutics, Inc-
Moderate Neutral
Protagonist Therapeutics Adopts 2026 Equity Incentive Plan
Stockholders approved a new equity compensation plan that replaces the company's 2016 plan and sets terms for stock and cash awards to employees, directors, and...